gs1-02: "randomized, double-blind, phase 3 study of pembrolizumab chemotherapy vs placebo..."
Published 1 year ago • 13 plays • Length 9:41Download video MP4
Download video MP3
Similar videos
-
9:59
gs1-01: "phase 3 study of pembrolizumab chemotherapy vs placebo chemotherapy as neoadjuvant..."
-
9:59
gs1-08: "cctgma.32, a phase iii randomized double-blind placebo controlled adjuvant trial of..."
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
3:49
keynote-522: neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs place...
-
34:12
keynote-522
-
1:39:39
probabilistic ml - lecture 6 - gaussian distributions
-
7:24
我是三陰性乳癌 該如何治療 1 何謂三陰性乳癌
-
2:53
react: effect of celecoxib vs placebo as adjuvant therapy on dfs among patients with breast cancer
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
10:37
gs4-09. quality of life results from olympia:
-
9:16
keynote-522: pembro ct vs placebo ct neoadjuvant followed adjuvant pembro vs placebo in tnbc
-
2:14
er positive, pr positive, her2 negative in breast cancer treatment - dr. nanda rajaneesh
-
5:25
neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs placebo for early-...
-
7:06
everolimus extends pfs for hr positive, her2 negative breast cancer
-
13:03
early tnbc - pembrolizumab chemotherapy: pathologic complete response in key subgroups
-
1:37
grhl2 controlled gene expression networks in luminal breast cancer
-
1:51
fgfr3: a new possible target for treating triple-negative breast cancer
-
0:55
how is triple-negative breast cancer treated?
-
7:09
javier cortes, asco20: key findings of the keynote-355 study
-
3:34
neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in os